Stifel Financial’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Stifel Financial’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-44,460	Closed	-$2.35M	–	2823
2017 Q4	$2.35M	Sell	44,460 -18,575	-29%	-$1.02M	0.01%	1075
2017 Q3	$3.58M	Sell	63,035 -13,486	-18%	-$790K	0.01%	868
2017 Q2	$4.58M	Buy	76,521 +21,410	+39%	+$1.22M	0.02%	755
2017 Q1	$2.97M	Buy	+55,111	New	+$2.71M	0.01%	913

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Stifel Financial's BIVV Position: Q1 2018 in Review

Stifel Financial sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 44,460 shares — an estimated $2.35M sold.

Stifel Financial first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $4.58M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Stifel Financial reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Stifel Financial sold 44,460 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $2.35M.
Stifel Financial first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Stifel Financial's Bioverativ Inc. Common Stock position peaked at $4.58M in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Stifel Financial's 13F filing for Q1 2018, filed 11 May 2018.